Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04648878 · ClinicalTrials.gov registry record · NA

A Comparison of Conventional Physical Therapy, Powered Exoskeleton, and Hybrid Physical Therapy With Exoskeleton

A NA study of Stroke, sponsored by Loma Linda University.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT04648878 is a NA study of Stroke that has completed, run by Loma Linda University. The registered enrollment target is 6 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04648878, a NA study of Stroke, has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this investigator-initiated study is to establish if powered exoskeleton therapy as a part of a rehabilitation program can be used as a standard of care in stroke rehabilitation.

Conditions Studied

Interventions

  • OTHER Hybrid combination of physical therapy and powered exoskeleton
  • OTHER Powered Exoskeleton Only
  • OTHER Physical Therapy only

Study Locations (1)

California

  • Loma Linda University - Loma Linda

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2021-02-14
Est. Completion 2024-12-18
Phase NA

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT04648878

The ClinicalTrials.gov registry entry for NCT04648878 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Hybrid combination of physical therapy and powered exoskeleton is the first listed.

NCT04648878 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04648878 about?

NCT04648878 is a clinical study titled "A Comparison of Conventional Physical Therapy, Powered Exoskeleton, and Hybrid Physical Therapy With Exoskeleton". The purpose of this investigator-initiated study is to establish if powered exoskeleton therapy as a part of a rehabilitation program can be used as a standard of care in stroke rehabilitation.

What is the current status of trial NCT04648878?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-02-14. Estimated completion is 2024-12-18.

What conditions does trial NCT04648878 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT04648878?

The interventions under investigation include: Hybrid combination of physical therapy and powered exoskeleton (OTHER), Powered Exoskeleton Only (OTHER), Physical Therapy only (OTHER).

Who is sponsoring clinical trial NCT04648878?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04648878 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.